"
Team:Paris Bettencourt/Human Practice/Overview
From 2013.igem.org
| (41 intermediate revisions not shown) | |||
| Line 1: | Line 1: | ||
| - | {{:Team:Paris_Bettencourt/ | + | {{:Team:Paris_Bettencourt/Wiki}} |
| + | {{:Team:Paris_Bettencourt/Menu}} | ||
<html> | <html> | ||
| + | <div style="width:1100px;margin:0 auto;"> | ||
| + | style="position:absolute;top:200px;right:30px;"/> | ||
| + | </div> | ||
| + | <img src="https://static.igem.org/mediawiki/2013/6/6a/PB_humanpracticebanner2.png"/> | ||
<style> | <style> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
.abstractile { | .abstractile { | ||
background:rgb(252,250,229); | background:rgb(252,250,229); | ||
width:100%; | width:100%; | ||
| - | height: | + | height:170px; |
margin-bottom:15px; | margin-bottom:15px; | ||
} | } | ||
| Line 37: | Line 33: | ||
.projtile2 { | .projtile2 { | ||
float:left; | float:left; | ||
| - | width: | + | width:541px; |
| - | height: | + | height:360px; |
background:rgb(252,250,229); | background:rgb(252,250,229); | ||
margin-bottom:15px; | margin-bottom:15px; | ||
| Line 60: | Line 56: | ||
</style> | </style> | ||
<div id="page"> | <div id="page"> | ||
| - | |||
<div class="abstractile"> | <div class="abstractile"> | ||
<div class="leftparagraph"> | <div class="leftparagraph"> | ||
| - | <p> | + | <p><b>Human practice thorough literature review and interviews with specialists (doctors, NGO, French and International officials) carried all the team to reflect upon global questions spanning from TB facts (past, present and future) to realizing the complexity of gender bias within infected TB population. |
| - | + | </b></p> | |
| + | </div> | ||
<div class="rightparagraph"> | <div class="rightparagraph"> | ||
| + | <p><b>This brought us to self-reflect on our own group and surrounding community that lead to the gender study in the synthetic biology and iGEM community brought to you here. We also addressed technology transfer through the TB R&D approach presented here.</b></p> | ||
</div> | </div> | ||
| - | |||
</div> | </div> | ||
| + | <div style="clear: both;"></div> | ||
<div class="projtile" style="margin-right:15px"> | <div class="projtile" style="margin-right:15px"> | ||
<a href="https://2013.igem.org/Team:Paris_Bettencourt/Human_Practice/TB_Facts" title="TB Facts"> | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Human_Practice/TB_Facts" title="TB Facts"> | ||
| Line 74: | Line 71: | ||
<!--<center><img src="" style="height:50px;margin-bottom:5px;"/></center>--> | <!--<center><img src="" style="height:50px;margin-bottom:5px;"/></center>--> | ||
</a> | </a> | ||
| + | <p>Infographics about TB data and facts that will show you what you need to know at a glance. | ||
| + | </p> | ||
</div> | </div> | ||
<div class="projtile" style="margin-right:15px"> | <div class="projtile" style="margin-right:15px"> | ||
| Line 80: | Line 79: | ||
<!--<center><img src="" style="height:50px;margin-bottom:5px;"/></center>--> | <!--<center><img src="" style="height:50px;margin-bottom:5px;"/></center>--> | ||
</a> | </a> | ||
| + | <p>An analysis of the social, medical and political aspects of the management of tuberculosis in France. | ||
| + | </p> | ||
</div> | </div> | ||
<div class="projtile"> | <div class="projtile"> | ||
| Line 86: | Line 87: | ||
<!--<center><img src="" style="height:50px;margin-bottom:5px;"/></center>--> | <!--<center><img src="" style="height:50px;margin-bottom:5px;"/></center>--> | ||
</a> | </a> | ||
| + | <p>A gallery of famous historic figures who had tuberculosis, from Antiquity to the 20th century. | ||
| + | </p> | ||
</div> | </div> | ||
<div style="clear: both;"></div> | <div style="clear: both;"></div> | ||
| Line 93: | Line 96: | ||
<!--<center><img src="" style="height:50px;margin-bottom:5px;"/></center>--> | <!--<center><img src="" style="height:50px;margin-bottom:5px;"/></center>--> | ||
</a> | </a> | ||
| + | <p>A comprehensive and quantitative study of gender (in)equality in iGEM and synthetic biology. When looking at TB epidemiological facts, women and men are not affected equally. The origins of this difference are both genetic and cultural. This brought us to self-reflect on our own community. We used a quantitative approach: a database was gathered to depict sex ratio in teams' students and supervisors in all iGEM teams as well as other available information. This was statistically analysed to investigate gender in(equality) in iGEM, as well as SB conferences and synthetic biology lab. | ||
| + | </p> | ||
</div> | </div> | ||
<div class="projtile2"> | <div class="projtile2"> | ||
| Line 99: | Line 104: | ||
<!--<center><img src="" style="height:50px;margin-bottom:5px;"/></center>--> | <!--<center><img src="" style="height:50px;margin-bottom:5px;"/></center>--> | ||
</a> | </a> | ||
| + | <p>Tackling the question of technology transfer in TB R&D field. Tuberculosis is most widespread in so-called “developing” countries. For this reason, it was impossible for us to work on this disease without taking into account the fact that we were designing in France a technology that was aimed precisely at those countries, rather than at “developed” ones: a typical case of technology transfer. | ||
| + | </p> | ||
</div> | </div> | ||
<div style="clear: both;"></div> | <div style="clear: both;"></div> | ||
</div> | </div> | ||
<div style="clear: both;"></div> | <div style="clear: both;"></div> | ||
| + | </div> | ||
</html> | </html> | ||
{{:Team:Paris_Bettencourt/footer}} | {{:Team:Paris_Bettencourt/footer}} | ||
Latest revision as of 16:46, 28 October 2013
Human practice thorough literature review and interviews with specialists (doctors, NGO, French and International officials) carried all the team to reflect upon global questions spanning from TB facts (past, present and future) to realizing the complexity of gender bias within infected TB population.
This brought us to self-reflect on our own group and surrounding community that lead to the gender study in the synthetic biology and iGEM community brought to you here. We also addressed technology transfer through the TB R&D approach presented here.
TB Facts
Infographics about TB data and facts that will show you what you need to know at a glance.
TB in France
An analysis of the social, medical and political aspects of the management of tuberculosis in France.
TB Gallery
A gallery of famous historic figures who had tuberculosis, from Antiquity to the 20th century.
Gender Study
A comprehensive and quantitative study of gender (in)equality in iGEM and synthetic biology. When looking at TB epidemiological facts, women and men are not affected equally. The origins of this difference are both genetic and cultural. This brought us to self-reflect on our own community. We used a quantitative approach: a database was gathered to depict sex ratio in teams' students and supervisors in all iGEM teams as well as other available information. This was statistically analysed to investigate gender in(equality) in iGEM, as well as SB conferences and synthetic biology lab.
Technology Transfer
Tackling the question of technology transfer in TB R&D field. Tuberculosis is most widespread in so-called “developing” countries. For this reason, it was impossible for us to work on this disease without taking into account the fact that we were designing in France a technology that was aimed precisely at those countries, rather than at “developed” ones: a typical case of technology transfer.
+33 1 44 41 25 22/25
team2013@igem-paris.org 
